Updating the role of matrix metalloproteinases in mineralized tissue and related diseases Bone development and healing processes involve a complex cascade of biological events requiring well-orchestrated synergism with bone cells, growth factors, and other trophic signaling molecules and cellular structures. Beyond health processes, MMPs play several key roles in the installation of heart and blood vessel related diseases and cancer, ranging from accelerating metastatic cells to ectopic vascular mineralization by smooth muscle cells in complementary manner. The tissue inhibitors of MMPs (TIMPs) have an important role in controlling proteolysis. Paired with the post-transcriptional efficiency of specific miRNAs, they modulate MMP performance. If druggable, these molecules are suggested to be a platform for development of "smart" medications and further clinical trials. Thus, considering the pleiotropic effect of MMPs on mammals, the purpose of this review is to update the role of those multifaceted proteases in mineralized tissues in health, such as bone, and pathophysiological disorders, such as ectopic vascular calcification and cancer. Bone is a specialized, vascular, and dynamic connective tissue in constant remodeling to maintain physiological ion homeostasis, give support and protection for soft tissue, and be a reservoir of ions important to vertebrates. 1-3 Mechanistically, bone remodeling requires a coordinate and dynamic relationship between deposition/degradation of extracellular matrix (ECM), through growth factors and other signaling molecules, which results in ECM remodeling-an important prerequisite for cell adhesion, migration, proliferation, differentiation. 4 It is well known that osteoclasts resorb the mineralized matrix and further promote the remodeling of the organic fraction of the bone, while, conversely, osteoblasts are responsible for bone formation by depositing specialized ECM components prior to mineralizing it properly 2 . The balance between those specialized cells is crucial for maintaining appropriate bone mass, and the lack of this synchronism contributes to the occurrence of bone diseases, such as osteoporosis and Paget's. To date, ultimate bone cellular differentiation is known to depend on wellorchestrated communication between formation and resorption events. 2,5-7 More specifically, during bone repair after trauma, bone healing depends on interactions between specific signaling inflammatory cytokines and non-resident and eventual cells (such as polymorphonuclear leukocytes and monocyte-macrophage lineage), 8 requiring ECM remodeling by specific matrix metalloproteinases (MMPs). Generally, MMPs are an important family of zinc-dependent endopeptidases and are the major class of enzymes responsible for the degradation or resorption of all ECM components (Figure 1). 9-15 MMP targets include other proteases, protease inhibitors, blood coagulation factors, chemotactic molecules, latent growth factors, binding protein growth factor, cell surface receptors, and cell adhesion molecules. 16-19 At this stage, bone remodeling is necessary for the homeostasis of systemic calcium release, bone turnover, and repair/regeneration of injured bone. 20 In turn, MMPs are important regulators of the cellular and physiological processes affecting crucial biological processes, such as angiogenesis, morphogenesis, tissue repair, and are decisive tools for the occurrence of some diseases, such as cancer, cardiovascular disorders, arthritis, among others. 21-23 Particularly, MMP-2 plays a role in bone embryonic development, tissue repair, and tumorigenesis, 24 while MMP-7 stimulates bone differentiation and extracellular matrix degradation, 25 and MMP-9 seems to be involved in osteoclast-based bone remodeling. 25,26 Generally, MMPs are secreted in latent form, such as pro-enzymes or zymogens, and therefore require proteolytic activation occurring after the precise removal of the inhibitory pro-peptide. This biochemical processing occurs by breaking the link between the cysteinecontaining thiol group and the zinc in the catalytic domain 27,28 , resulting in an optimal conformational structure for exerting catalysis mechanisms. MMPs are classified respecting their structure and/or their specific substrates, resulting in a family of 25 members actually (Figure 2). 18,29 Conversely, TIMPs are responsible for controlling the breakdown of ECM components by negatively modulating MMPs and they are involved in a range of important biological phenomena and pathological events such as inflammation and tumor invasion. It is known that the TIMPs range of activities can be even wider if we consider their effect on the inhibition of several ADMs and ADMTSs (disintegrins and metalloproteinases). 19,30
Introduction breakdown and drive cell fates involved with adhesion, proliferation, differentiation mechanisms, such as well as releasing signaling active molecules during the remodeling process of the hematoma tissue. In this scenario, MMPs are particularly important members controlling this mechanism and their regulation is decisive to adequate bone healing. Because MMPs participate in almost all phases of bone repair, they are important biomarkers of this very complex and coordinated process. 16, 35 To the best of our
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MMP-1 TIMP-4 Radomski, et al. 9 The ECM remodeling requires specific activities of MMPs. The literature reports an increase in MMPs 2, -3, -9, -13, in osteoblast that leads to bone resorption by stimulating interleukin-1 and -6. 4, 24 The role of each MMP involved in bone remodeling is not fully clear, but it is known that MMP-2, -13, and -14 plays an essential role. In fact, due to the proteolytic activity of the bone matrix, regulation bioavailability of soluble RANKL, cell-cell interaction, Figure 4 ). 4, 20, 24, 47 In addition, our group has shown a molecular mechanism involved in osteoblast differentiation in vitro, requiring the expression of MMP-9, with higher expression on the 28 th day. 3 Furthermore, this study showed that both MMP -2 and -9 were regulated during osteoblast differentiation and apparently TIMP-2 was essential in the late osteoblast maturation. As seen, recent studies highlight the important involvement of proteases in the extracellular matrix solubilization process, their role in determining where and when the reabsorption will start, and its relationship with new bone formation.
However, little is known about the molecular details involved in such process, which makes research in this field focused on the discovery and identification of proteinases. 47 In addition to TIMPs, another endogenous MMP inhibitor was discovered recently: RECK ("reversioninducing cysteine-rich protein with Kazal motifs"). 48 RECK is a membrane-anchored glycoprotein capable of negatively regulating peri-cellularly MMPs and compromises ECM remodeling, triggering signaling pathways, such as Notch, which is essential for the process of angiogenesis. 3, 49 Because of this, RECK has been considered a prognostic marker and potential therapeutic macromolecule in solid cancers. However, although some progress has been achieved highlighting Also concerning craniofacial structures, Demarchi, et al. 50 (2010) showed differential, temporal, and suggested RECK might reorganize the epithelium and mesenchyme palatine blades. Additionally, we have also dedicated to evaluate the involvement of MMPs and their inhibitors in adaptive osteoblast processes to biomaterials, and it is clear that ECM remodeling is a prerequisite to drive cell adhesion on biomaterials surfaces. [51] [52] [53] [54] [55] Although bone healing is a physiological mechanism able to regenerate enough tissue to heal small injuries, larger lesions require therapeutic alternatives to support bone growth. In this context, bone tissue engineering emerges as an interesting field within regenerative medicine, providing strategies to regenerate lost bone and thereafter restoring their physiological function. 3 In this aspect, the cooperation of biology, chemistry, physic, engineering, and biomedicine is established to evaluate biomaterials serving as scaffold for bone growth. The studies have focused on classifying metallic, organic, and inorganic materials regarding international rules of biocompatibility. Thus, we have tested the hypothesis that MMP-9 may be involved in tissue remodeling in response to xenogeneic hydroxyapatite, due to MMP-9 role in the breakdown of extracellular matrix components. The presence of CD68+ cells in response to natural hydroxyapatite was also investigated. The results suggest that tissue remodeling in response to natural hydroxyapatites requires MMP-9 expression and CD68+ cell recruitment. 3 This was also extended to the MMP2 role in reactive tissue in response to granules of hydroxyapatite. 56 To date, CD68 is a macromolecule widely found in macrophages and here they were discussed to drive osteoclastogenesis. 3 Thus, it is essential the balance between It has also been observed that EVs share structures homologous to those with matrix vesicles (MVs), which are characteristic of matrix mineralization, such as mineralization of cartilage, bone and dentin, for example. 36 EVs are released by plasma membranes, differentiating chondrocytes growth, odontoblasts, and osteoblasts. 36, 59 In general, these MVs contain matrix processing enzymes, such as MMP-2, MMP-9 and MMP-13, which play an important role in matrix remodeling, mainly degradation of proteoglycans, and allow calcification. cytokines, and chemokines, profoundly influence stem cell fates. 71 The complete understanding of the extracellular matrix remodeling is crucial to deliver signals guiding cellular phenotypes and, as expected, MMPs are discussed as important proteases in this context. In conjunction, MMPs play several key roles in the metastasis mechanism and might contribute to all stages of tumor progression and implantation. 71, 72 Molecularly, there are more than 500 genes encoding proteases or protein-like proteases in the human genome. 73 components of the extracellular matrix. 71 MMPs, especially MMP-2 and MMP-9 (both known as gelatinases A and B, respectively), are involved in several mechanisms contributing to cell adhesion and invasion, and further tumor progression. 39, 40, 76 The action of proteases assures the breakdown of barriers of ECM matrix components, mainly collagen, laminins, and proteoglycans, and favors cell invasion, thus driving the pathway to orchestrate invasive cancer cells. 71 74, 75 In health, MMP-2 (gelatinase A) is involved in many physiological factors and processes, including healing and repair as discussed earlier here. However, in tumor tissues such as osteosarcoma, the MMP-2 gene is overexpressed and contributes to the acceleration of extracellular components turnover and breakdown. Overall, MMP expression plays a crucial role in the development of osteosarcoma and consequently developing pulmonary metastasis in many individuals. 39, 40 In this way, Zhang & Zhang 40 (2015) found MMP-2 involvement was higher in the individuals presenting osteosarcoma than in the control group. Moreover, the overall survival rate was higher in individuals with negative MMP-2 expression, and the group presenting negative expression of MMP-2 lived longer than the group with those positive expressions. In addition, they show that abnormal expression of MMP-2 was associated with pulmonary metastasis. Fang, et al. 77 (2000) found many other roles of MMP-2 in tumor progression, such as their involvement with EGFR signaling and integrin, which leads to cell migration and the shift to an angiogenic phenotype. Thus, it is clear that MMP develops a pleiotropic effect on tumor installation by remodeling ECM and activating signaling molecules, impacting cell adhesion and metastatic phenotype ( Figure 5 ). [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] Studies suggested that MMPs are involved in initial step of ECM degradation during metastatic process. 5, 22, 40, 72 
Osteoarthritis
Chang, et al. 92 (2018) miRNA144 MMP-28 MMP-28 is downregulated by miRNA144, involved in mechanism of tumor proliferation and migration.
Colorectal cancer
Xiao, et al. 93 (2015) Figure 5 -Summary of the miRNAs effect over MMPs in some diseases [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] Updating the role of matrix metalloproteinases in mineralized tissue and related diseases J Appl Oral Sci. 2019;27:e20180596 9/14 also important in genes encoding MMPs and they lead to changes in MMP expression patterns in cancer. 104 The relations between the MMP overproduction in tumor or stromal cells and the progression of cancer led to the development of clinical trials testing a series of inhibitors intended to block the proteolytic activity of these enzymes. However, the application of MMP inhibitors in patients was unsuccessful because some MMPs may play a paradoxical protective role in tumor progression along with the identification of new roles of MMPs in the initial stages of cancer. 74, 75 MMPs and specific inflammatory landscape 43, 44 In the study by Zeng, et al. 45 (2015) , protein levels of MMP-1, MMP-2 and MMP-9 were higher in patients with OA compared to the control group, and the ethnicity showed that levels of MMP-1 and MMP-2 were higher in Asians with OA compared to the control group. However, the levels of MMP-9 in OA patients were higher than that of control group, Asians and Caucasians. 45 Additionally, the matrix metalloproteinases are responsible for collagen and ECM degradation, in periodontal disease. 106 MMP-8 and MMP-13 related to tissue destruction followed with significant contribution of MMP-9 and MMP-14. 46 
MMPs and ectopic vascular calcification
As above-mentioned, mineralization is not an exclusive mechanism of bone. more specifically, ectopic vascular calcification has become an important topic in public health and over the last years, several studies have shown the important involvement of MMPs and TIMPs in cardiovascular diseases, including coronary artery disease, 107 myocardial infarction, 108 atherosclerosis, 109 and ischemic stroke. 110, 111 In cardiovascular diseases, MMPs act in the weakening of vessels since they are able to degrade all their major components, essential for the maintenance of vascular tonus. 112 The main MMPs involved in cardiovascular diseases are MMP-2 and MMP-9. 41, 42 We have shown recently that the mechanostimulation of smooth muscle cells provokes hypermethylation of the TIMP1 promotor, resulting in a decrease of TIMP1 transcription and translation in conjunction with an increased matrix remodeling enzymatic activity.
Therefore, we have defined a novel-signaling pathway responsible for the physiological adaptation of vessel smooth muscle to changes in mechanical pressure, which are potentially relevant for defining novel avenues for the rational treatment of diseases. 113 Chemical-motivated inhibitors of MMPs have been shown to be promising strategies for cardio-protection.
Bencsik, et al. 114 (2014) found that the inhibitor of MMP ilomastat was able to moderately inhibit the expression of MMP-2 in rats with induced myocardial infarction, which led to the conclusion that its function EGCG is an important polyphenol of green tea with a potential chemotherapeutic agent demonstrating antimetastatic and MMP inhibitory activities in addition to various other already known biological activities. 118, 120 Additionally, the effects of EGCG were also evaluated in anti-proliferation and anti-migration against bladder cancer SW780 cells for both in vitro and in vivo. Thebiology of MMPs is thus very complex and has been listed within several pathologies, and as such further studies are necessary evaluating these proteases as promising therapeutic strategies. 116 However, it is important to note that further investigation is urgent for determining the clinical efficacy and safety of these 
Treatment of EGCG resulted in significant inhibition
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